Skip to main content

In vivo immunostimulation by tuftsin

Cancer Immunology, Immunotherapy volume 5, pages 211–216 (1978)Cite this article

Summary

Tuftsin, a physiological basic tetrapeptide known for its capacity to stimulate the phagocytic activity of macrophages and polymorphonuclear leucocytes, was examined for its immunostimulating properties when injected systemically into mice.

Tuftsin was able to potentiate the antibody response to a thymus-dependent antigen (TNP-KLH) when injected 3, 7 or 10 days before the antigen. The response to the same hapten coupled to a thymus-independent carrier (LPS) was stimulated on day 1 and 3 but slightly depressed on day 7.

The peptide rendered macrophages highly cytostatic for tumor cells but the activation process required 7 days to develop. In contrast, enhancement of antibody-dependent cell-mediated cytotoxic (ADCC) activity of spleen cells was observed throughout the period of observation (14 days).

Tuftsin did not induce nonspecific suppressor cells as the response of normal spleen cells to mitogens in vitro was not depressed when cultivated in the presence of tuftsin-treated spleen cells.

These observations suggest that tuftsin acts as an immunostimulant which may be useful in cancer immunotherapy.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. CUNNINGHAM A.J., SZENBERG A.: Further improvement in the plaque technique for detecting single antibody-forming cells. Immunology, 14, 599, 1968.

    Google Scholar 

  2. FINK M.A. : The macrophages in neoplasias, edited by Fink M.A., Academic Press, 1976, 1 vol.

  3. FLORENTIN I., HUCHET R., BRULEY-ROSSET M., HALLE-PANNENKO O., and MATHE G.: Studies on the mechanism of action of BCG. Cancer Immunol. Immunoth., 1976, 1, 31.

    Google Scholar 

  4. FLORENTIN I., KIGER N., BRULEY-ROSSET M., SCHULZ J. and MATHE G. : Effect of seven immuno-modulators on different types of immune responses in mice. In “Human lymphocyte differentiation : its application to cancer. Edited by B. Serrou and C. Rosenfeld, Elsevier/North-Holl and Biomed. Press, 1978, p. 299.

  5. FLORENTIN I., BRULEY-ROSSET M., DAVIGNY M. and MATHE G. : Comparison of the effects of BCG and a preparation of heat-killed Pseudomonas aeruginosa on the immune responses in mice. In : The pharmacology of immunoregulation, edited by G.H. Werner and F. Floc'h, Academic Press, 1978, p. 325.

  6. FRIDKIN M., ZARUTH V. and SPIRER Z.: Tuftsin and some analogs. Synthesis and interactions with polymorphonuclear leukocytes. Biochem. Biophys. Acta., 1977, 496, 203.

    Google Scholar 

  7. GHAFFAR A., CALDER A.: K cell cytotoxicity against antibody-coated chicken erythrocytes in tumor bearing mice. Its development with progressively growing tumor and effect of immunization against tumor. J. Immunol., 1976, 116, 315.

    Google Scholar 

  8. GREENBERG A.H., SHEN L., and NEDLEY G.: Characterization of the effector cells mediating cytotoxicity against antibody-coated target cells. Immunology, 1975, 29, 719.

    Google Scholar 

  9. HARADA M., PEARSON G., REDNON L., WINTERS E., KASUGA G.: Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system. J. Immunol., 1975, 114, 1318.

    Google Scholar 

  10. JUY D. and LECLERC C.: Enhancement of anti-body-dependent cell-mediated cytotoxicity by an interphase material (IPM) extracted from a non-pathogenic strain of mycobacteria. Cancer Immunol. Immunoth., 1977, 3, 23.

    Google Scholar 

  11. KLIMPEL G.R. and HENNEY C.S.: BCG induced suppressor cells. I— Demonstration of a macrophage like suppressor cell that inhibits cytotoxic T cell generation in vitro. J. Immunol., 1978, 120, 563.

    Google Scholar 

  12. KONOPINSKA D., NAWROCKA E., SIEMION I.Z., SZYMANIEC and SLOPEK S.: Synthetic and conformational studies with tuftsin and its analog. Int. J. Peptide Res., 1977, 9, 71.

    Google Scholar 

  13. LEMKE H., COUTINHO A., OPITZ H.G. and GRONOWICZ: Macrophages suppress direct B cell activation by lipopolysaccharide. Scand. J. Immunol., 1975, 4, 707.

    Google Scholar 

  14. MARTINEZ J., WINTERNITZ F., and VINDEL J. : Nouvelles synthèses et propriétés de la tuftsine. Eur. J. Med. Chem., in press.

  15. MORAHAN P.S., KAPLAN A.M.: Macrophage activation and anti-tumor activity of biologic and synthetic agents. Int. J. Cancer, 1976, 17, 82.

    Google Scholar 

  16. NAJJAR V.A., NISHIOKA K.: “Tuftsin” : a natural phagocytosis stimulating peptide. Nature, 1970, 228, 672.

    Google Scholar 

  17. NAJJAR V.A.: Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide Thr-Lys-Pro-Arg, tuftsin. Exptl. Cell. Biol., 1978, 46, 114.

    Google Scholar 

  18. NELSON D.L., BUNDY B.M., PITCHON H.E., BIAESE R.M., STROBER W.: The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J. Immunol., 1976, 117, 1472.

    Google Scholar 

  19. NISHIOKA K., SATOH P., COSTANTOPOULOS A., and NAJJAR V.A.: The chemical synthesis of the phagocytosis stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties. Biochem. Biophys. Acta, 1973, 310, 230.

    Google Scholar 

  20. NISHIOKA K.: Migration enhancement by tuftsin of human mononuclear cells and its effects on the migration inhibition factor test with tumor antigens. Gann, 1978, 69, 569.

    Google Scholar 

  21. OLSSON L., FLORENTIN I., KIGER N. and MATHE G. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia J. Nat. Cancer Inst., 1977, 59, 1297.

    Google Scholar 

  22. SCHULTZ R.M., PAPAMATHEAKIS D., LUETZELER J., and CHIRIGOS M.A.: Association of macrophage activation with antitumor activity by synthetic and biological agents. Cancer Res., 1977, 37, 3338.

    Google Scholar 

  23. SCOTT M.T.: Biological effect of the adjuvant Corynebacterium parvum. I— Inhibition of PHA, mixed lymphocyte and GVH reactivity. Cell. Immun. 1972, 5, 459.

    Google Scholar 

  24. TAGLIABUE A., MANTOVANI A., POLENTARUTTI N., VECCHI A. and SPREAFICO F.: Effect of immunomodulators on effector cells involved in antibody-dependent cellular cytotoxicity. J. Nat. Cancer Inst., 1977, 59, 1019.

    Google Scholar 

  25. TZEHOVAL E., SEGAL S., STABINSKY Y., FRIDKIN M., SPIRER Z., and FELDMAN M.: Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages : implication for activation on programmed cells. Proc. Natl. Acad. Sci., 1978, 75, 3400.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut de Cancérologie et d'Immunogénétique (U50 INSERM), Hôpital Paul Brousse, 16 avenue Paul Vaillant Couturier, F-94800, Villejuif, France

    I. Florentin, M. Bruley-Rosset, N. Kiger & G. Mathé

  2. Laboratoire de Chimie Bio-organique, Université des Sciences et Techniques du Languedoc, F-34060, Montpellier, France

    J. L. Imbach & F. Winternitz

Authors
  1. I. Florentin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bruley-Rosset
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Kiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. L. Imbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Winternitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Mathé
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by grants from DGRST (no 78.7.2651) and from INSERM (contract libre no 78.5.168.2).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Florentin, I., Bruley-Rosset, M., Kiger, N. et al. In vivo immunostimulation by tuftsin. Cancer Immunol Immunother 5, 211–216 (1978). https://doi.org/10.1007/BF00199631

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199631

Keywords

  • Peptide
  • Tumor Cell
  • Cancer Research
  • Antibody Response
  • Activation Process